Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by R Plagne
Potential Allogeneic Graft-Versus-Tumor Effect in a Patient With Ovarian Cancer
Bone Marrow Transplantation
Transplantation
Hematology
Mobilization of Peripheral Blood Progenitor Cells After Induction Chemotherapy (THP-doxorubicin-vinorelbine-cyclophosphamide-fluorouracil) and Granulocyte Colony-Stimulating Factor in Breast Cancer
Bone Marrow Transplantation
Transplantation
Hematology
Related publications
Allogeneic Stem Cell Transplantation After Reduced-Intensity Conditioning in a Patient With T-Cell Prolymphocytic Leukemia: Graft-Versus-Tumor Effect and Long-Term Remission
Bone Marrow Transplantation
Transplantation
Hematology
Graft-Versus-Tumor Effect After Allogeneic Stem Cell Transplantation in HIV-Positive Patients With High-Risk Hematologic Malignancies
AIDS Research and Human Retroviruses
Virology
Infectious Diseases
Immunology
Autologous Graft-Versus-Tumor Effect: Reality or Fiction?
Advances in Hematology
Hematology
Brain Metastases in a Patient With Ovarian Cancer
International Journal of Neurologic Physical Therapy
Influence of Ultraviolet-B Irradiation on Engraftment, Graft-Versus-Host Disease and Graft-Versus-Leukemia Effect in a Rat Model for Allogeneic Bone Marrow Transplantation
Bone Marrow Transplantation
Transplantation
Hematology
Evidence of Graft-Versus-Tumour Effect Following Allogeneic Haematopoietic Stem Cell Transplantation in Renal Cancer Other Than Clear Cell Type
Bone Marrow Transplantation
Transplantation
Hematology
Lenalidomide-Induced Graft-Vs.-Leukemia Effect in a Patient With Chronic Lymphocytic Leukemia Who Relapsed After Allogeneic Stem Cell Transplant
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Evidence of Graft-Versus-Waldenstrom's Macroglobulinaemia Effect After Allogeneic Stem Cell Transplantation: A Single Centre Experience
Bone Marrow Transplantation
Transplantation
Hematology
Lenalidomide Induced Graft-Versus-Host Disease in a Patient With Relapsed Multiple Myeloma Three and a Half Years After Allogeneic Hematopoietic Stem Cell Transplantation
Journal of Hematopoietic Cell Transplantation